Welcome to our dedicated page for Movano SEC filings (Ticker: MOVE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Movano Inc. (Nasdaq: MOVE) SEC filings page on Stock Titan provides direct access to the company’s official regulatory disclosures, along with AI-powered summaries that help explain their contents in plain language. Movano, doing business as Movano Health, files a range of documents with the U.S. Securities and Exchange Commission that together outline its wearable health technology business, capital structure, and significant corporate events.
Investors can review registration statements such as the Form S-1 that describes a committed equity facility with Chardan Capital Markets LLC, including the potential issuance of up to 110,000,000 shares of common stock under the facility and Movano’s status as an emerging growth company and smaller reporting company. The S-1 and related materials also discuss Nasdaq listing matters, reverse stock split effects on share counts, and stockholders’ equity considerations.
Current reports on Form 8-K document material events, including the Agreement and Plan of Merger with Corvex, Inc., the structure of the all-stock combination, expected ownership percentages of the combined company, and conditions to closing. Other 8-K filings cover the one-for-ten reverse stock split, Nasdaq deficiency notices and extensions, amendments to incentive plans, preferred stock financings, amendments to loan agreements, and stockholder meeting results. These filings provide detail on how Movano is addressing listing requirements, financing needs, and its planned transformation through the Corvex merger.
Definitive proxy statements on Schedule 14A offer insight into stockholder votes on matters such as increasing authorized share capital, approving share issuances under the ChEF Purchase Agreement, amending the omnibus incentive plan, and authorizing reverse stock splits. They also describe virtual special meeting logistics and voting procedures for common and preferred stockholders.
On Stock Titan, each filing is accompanied by AI-generated highlights that point out key terms, risk factors, and structural details, helping users navigate lengthy documents like S-1 registration statements and complex 8-K merger disclosures. The platform also makes it easier to locate quarterly and annual reports when filed (Forms 10-Q and 10-K), as well as any insider transaction reports on Form 4, so users can monitor executive and director share dealings once available.
By using this page, investors can quickly find Movano’s official SEC filings related to its wearable medical devices, financing arrangements, Nasdaq compliance efforts, and the proposed renaming and repositioning of the company as Corvex, Inc. after the merger closes, while relying on AI tools to surface the most important information from each document.
Movano Inc. reported that Nasdaq has notified the company it is not in compliance with listing rules because it did not file its Form 10-Q for the quarter ended June 30, 2025 by the August 14, 2025 deadline. This violates Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic reports with the SEC.
The company previously faced a delisting determination and on August 19, 2025 presented a compliance plan to a Nasdaq Hearing Panel covering both the late filing issue and the $1.00 minimum bid price requirement under Listing Rule 5550(a)(2). Movano is awaiting the Panel’s decision, and there is no assurance the Panel will stay any suspension of trading or allow the company time to execute its plan and regain compliance with Nasdaq listing standards.
Movano Inc. is soliciting proxies for its September 26, 2025 annual meeting to vote on four proposals: election of two Class I directors (Emily Wang Fairbairn and Michael Leabman), approval of an amendment to effect a board-determined reverse stock split at a ratio between 1-for-2 and 1-for-15, approval to increase authorized common shares from 500,000,000 to 2,000,000,000, and ratification of the Audit Committee’s selection of RBSM LLP as independent auditors for fiscal 2025. The Board recommends voting FOR all proposals. The company disclosed it received a Nasdaq notice for failure to maintain a minimum $1.00 bid price and for a late Form 10-Q filing and has appealed the delisting determination; the reverse split proposal is presented as a remedy. The proxy materials include director biographies, committee charters, compensation practices and employment arrangements. The filing contains placeholders where the exact number of shares outstanding and certain record-date ownership figures should appear.
Movano Inc. filed an NT 10-Q notice for the period ended June 30, 2025 from its Pleasanton, CA address. The form indicates the company does not anticipate any significant change in results of operations compared with the corresponding period of the prior fiscal year. The notice is signed by the Chief Financial Officer, J. Cogan, dated August 15, 2025. The filing provides no earnings figures or additional financial detail.
Movano Inc. engaged RBSM LLP as its new independent registered public accounting firm for the fiscal year ending December 31, 2025, including interim periods. The decision was approved by the company’s Audit Committee.
Movano states that for the fiscal years ended December 31, 2024 and 2023, and through RBSM’s engagement date, it did not consult RBSM on the application of accounting principles, potential audit opinions, or other accounting, auditing, or financial reporting issues. The company also notes there were no consultations with RBSM on any matter involving disagreements or reportable events as defined under SEC rules.
FAQ
What is the current stock price of Movano (MOVE)?
What is the market cap of Movano (MOVE)?
